Related Experiment Video
Updated: Sep 2, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Left ventricular assist device implantation following multisystem inflammatory syndrome in children due to SARS-CoV-2
Oguz Konukoglu1, Ali Dogan2, Kenan Sever1
1Gaziosmanpasa Hospital Cardiovascular Surgery Department, Faculty of Medicine, Istanbul Yeni Yuzyil University, Istanbul, Turkey.
Insights
Multisystem inflammatory syndrome in children (MIS-C) can cause severe heart failure. This case report details a child requiring mechanical circulatory support, including ECMO and a ventricular assist device, for acute left ventricular failure.
Area of Science:
- Pediatrics
- Cardiology
- Infectious Diseases
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition following SARS-CoV-2 infection.
- A subset of MIS-C patients develops severe cardiac complications, including acute heart failure.
- Left ventricular failure is a critical manifestation requiring intensive management.
Abstract:
Multisystem inflammatory syndrome in children (MIS-C) is rare, however, severe hyperinflammatory condition in children generally weeks after acute SARS-CoV-2 infection. A subset of MIS-C patients is presented with severe heart failure. We hereby report 8-year-old girl presenting acute severe left ventricular failure. Various medical treatments including inotropic agents and drugs related to SARS-CoV-2 infection and MIS-C were applied. However, venoarterial extracorporeal membrane oxygenation (ECMO) was needed to be performed. Due to unsuccessful attempts for ECMO weaning, left ventricular assist device was implanted to the patient with temporary right ventricular support from ECMO.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy

